Posted on 02 May 2011
Tags: big pharma, Cephalon, Teva
Now that Teva Pharmaceutical Industries has snatched Cephalon, what's next for would-be suitor Valeant Pharmaceuticals?
More deals, naturally...
Read the Valeant story at Reuters.
Click here to cancel reply.
Email (will not be published) (required)
Your website (optional)
© 2020 Wildwood Ventures Ltd.